Compare BLCO & TRNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLCO | TRNO |
|---|---|---|
| Founded | 1853 | 2009 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 6.8B |
| IPO Year | 2022 | 2009 |
| Metric | BLCO | TRNO |
|---|---|---|
| Price | $16.68 | $62.09 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 12 |
| Target Price | $18.55 | ★ $67.83 |
| AVG Volume (30 Days) | 429.4K | ★ 581.2K |
| Earning Date | 05-21-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.32% |
| EPS Growth | N/A | ★ 103.65 |
| EPS | N/A | ★ 3.91 |
| Revenue | ★ $5,101,000,000.00 | $476,383,000.00 |
| Revenue This Year | $8.61 | $7.62 |
| Revenue Next Year | $5.52 | $8.75 |
| P/E Ratio | ★ N/A | $16.05 |
| Revenue Growth | 6.47 | ★ 24.51 |
| 52 Week Low | $10.45 | $53.00 |
| 52 Week High | $18.92 | $67.70 |
| Indicator | BLCO | TRNO |
|---|---|---|
| Relative Strength Index (RSI) | 38.45 | 38.79 |
| Support Level | $16.35 | $59.00 |
| Resistance Level | $16.81 | $62.75 |
| Average True Range (ATR) | 0.51 | 1.15 |
| MACD | -0.16 | -0.54 |
| Stochastic Oscillator | 0.22 | 25.01 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Terreno Realty Corp is a real estate investment trust engaged in acquiring, owning, and operating industrial real estate in six coastal U.S. markets: Los Angeles, Northern New Jersey/New York City, San Francisco Bay Area, Seattle, Miami, and Washington, D.C. The company invests in several types of industrial real estate, including warehouse/distribution, flex (including light industrial and research and development), transshipment, and improved land.